Cargando…

IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma

BACKGROUND: Recent genome-wide association studies revealed the rs12979860 single nucleotide polymorphism (SNP) of the IL28B gene (CC genotype) to be the strongest pre-therapeutic predictor of therapy response to interferon alpha in patients with chronic hepatitis C infection. The favorable CC genot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Probst, Martin, Hoeller, Christoph, Ferenci, Peter, Staettermayer, Albert F., Beinhardt, Sandra, Pehamberger, Hubert, Kittler, Harald, Grabmeier-Pfistershammer, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229256/ https://www.ncbi.nlm.nih.gov/pubmed/25389973 http://dx.doi.org/10.1371/journal.pone.0112613

Ejemplares similares

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
por: Zoller, Heinz, et al.
Publicado: (2015)

Sentinel node status in melanoma patients is not predicitive for overall survival upon multivariate analysis
por: Roka, F, et al.
Publicado: (2005)

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
por: Tschandl, Philipp, et al.
Publicado: (2013)

Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy
por: Strassl, Robert, et al.
Publicado: (2015)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

Not All Immune Checkpoints Are Created Equal
por: De Sousa Linhares, Annika, et al.
Publicado: (2018)

The order of things and the classification of melanoma
por: Kittler, Harald
Publicado: (2012)

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
por: Scheiner, Bernhard, et al.
Publicado: (2015)

How to Combat Over, diagnosis of Melanoma
por: Kittler, Harald
Publicado: (2023)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

Evolution of the Clinical, Dermoscopic and Pathologic Diagnosis of Melanoma
por: Kittler, Harald
Publicado: (2021)

Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study
por: Scheiner, Bernhard, et al.
Publicado: (2016)

Late versus non-late presentation of HIV/AIDS: an economic impact analysis
por: Grabmeier-Pfistershammer, K, et al.
Publicado: (2010)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
por: Younossi, Zobair M, et al.
Publicado: (2012)

Manipulating the Alpha Level Cannot Cure Significance Testing
por: Trafimow, David, et al.
Publicado: (2018)

TIM-3 Does Not Act as a Receptor for Galectin-9
por: Leitner, Judith, et al.
Publicado: (2013)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Tumour necrosis factor alpha, interleukin 1 beta and interferon gamma have detrimental effects on equine tenocytes that cannot be rescued by IL-1RA or mesenchymal stromal cell–derived factors
por: Smith, Emily J., et al.
Publicado: (2022)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013)

Evaluation of interferon alpha 2b as adjunctive therapy for conjunctival melanoma
por: Benage, Matthew J., et al.
Publicado: (2019)

Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria
por: Herout, Sandra, et al.
Publicado: (2016)

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria
por: Grabmeier-Pfistershammer, Katharina, et al.
Publicado: (2019)

Morphologic characteristics of nevi associated with melanoma: a clinical, dermatoscopic and histopathologic analysis
por: Alendar, Temeida, et al.
Publicado: (2018)

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998)

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report
por: Grabmeier-Pfistershammer, K., et al.
Publicado: (2012)

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
por: Cameron, D A, et al.
Publicado: (2001)

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
por: Håkansson, A., et al.
Publicado: (1996)

Metastatic melanoma patients’ sensitivity to ipilimumab cannot be predicted by tumor characteristics
por: Rossfeld, Kara, et al.
Publicado: (2017)

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
por: Stecher, Carmen, et al.
Publicado: (2017)

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
por: Wagner, Angelika, et al.
Publicado: (2022)

Functional Classification of Cellular Proteome Profiles Support the Identification of Drug Resistance Signatures in Melanoma Cells
por: Paulitschke, Verena, et al.
Publicado: (2013)

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010)

Management of pediatric ‘cannot intubate, cannot oxygenate’
por: Okada, Yohei, et al.
Publicado: (2017)

Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a.
por: Hoffmann, R., et al.
Publicado: (1998)

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
por: Zhu, Haizhen, et al.
Publicado: (2005)

Growth rate of melanoma in vivo and correlation with dermatoscopic and dermatopathologic findings
por: Beer, Jürgen, et al.
Publicado: (2011)

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma
por: Suarez, Lorena P., et al.
Publicado: (2016)

Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
por: García-Ortega, María Belén, et al.
Publicado: (2023)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5lrasnhjsvf53bh6s2o06o66nr